Joris G. Heetman

Nieuwegein, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancer.

Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancer.

Journal: BJU international
Published: April 20, 2026

Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomy.

Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomy.

Journal: European journal of nuclear medicine and molecular imaging
Published: April 17, 2025

External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer.

External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging
Published: January 26, 2025

Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study.

Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study.

Journal: European urology open science
Published: August 05, 2024

The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy.

The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy.

Journal: European urology oncology
Published: August 05, 2024

PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience From a Multicenter Cohort.

PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience From a Multicenter Cohort.

Journal: Urology
Published: June 04, 2024

The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis.

The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis.

Journal: European journal of nuclear medicine and molecular imaging
Published: January 19, 2024

The additional value of 68Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy.

The additional value of 68Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy.

Journal: The Prostate
Published: November 24, 2023

Correction: Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?

Correction: Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?

Journal: World journal of urology
Published: September 21, 2023

External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension.

External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension.

Journal: Prostate cancer and prostatic diseases
Published: August 17, 2023

Immunohistochemical and histopathological validation of 18 F-PSMA-1007 PET/CT for intraprostatic cancerous lesions.

Immunohistochemical and histopathological validation of 18 F-PSMA-1007 PET/CT for intraprostatic cancerous lesions.

Journal: The Prostate
Published: February 23, 2023

Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?

Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?

Journal: World journal of urology
Published: December 21, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026